National Survey on Hypertension at Hospital (PROPHYL HO)
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00695266
First received: June 9, 2008
Last updated: August 4, 2009
Last verified: August 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.
| Condition |
|---|
|
Hypertension |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Profile of Hypertensive Patients Seen in Hospital Outpatient's Department |
Resource links provided by NLM:
Further study details as provided by AstraZeneca:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
First five consecutive patients with hypertension seen by Cardiologists
Criteria
Inclusion Criteria:
- Known hypertension
- agree to take part in this study
Exclusion Criteria:
- none
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00695266
Show 120 Study Locations
Show 120 Study LocationsSponsors and Collaborators
AstraZeneca
More Information
No publications provided
| Responsible Party: | Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals |
| ClinicalTrials.gov Identifier: | NCT00695266 History of Changes |
| Other Study ID Numbers: | NIS-CFR-DUM-2007/5 |
| Study First Received: | June 9, 2008 |
| Last Updated: | August 4, 2009 |
| Health Authority: | France: French Data Protection Authority |
Additional relevant MeSH terms:
|
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013